Braftovi

(encorafenib)
BRAFTOVI 50 MG Oral CapsuleBRAFTOVI 75 MG Oral Capsule
NO BOXED WARNING

Dosage & administration

drug label

Braftovi prescribing information

samples

Request Braftovi samples

Online Sample Form
Learn More

prior authorization

Braftovi prior authorization resources

Most recent Braftovi prior authorization forms

View By Payer
Verified: Feb 07, 2024Kaiser Foundation Health Plan - Chronic High-Dose Opioid Therapy Prior Authorization Form Washington
Verified: Mar 02, 2024Highmark BCBS Northeastern NY - Medicare Prescription Drug Medication Request Form
Verified: Mar 02, 2024Highmark BCBS Northeastern NY - Short Acting Opioid Prior Authorization Form
Verified: Mar 02, 2024Highmark BCBS Western NY - Specialty Drug Prior Authorization Form
Verified: Mar 02, 2024Highmark BCBS Western NY - Non-Formulary Drug Coverage Prior Authorization Form

Most recent state uniform prior authorization forms

Verified: Feb 27, 2024Arizona - Uniform Prior Authorization Form
Verified: Feb 27, 2024Colorado - Uniform Prior Authorization Form
Verified: Feb 27, 2024Hawaii - Uniform Prior Authorization Form
Verified: Feb 27, 2024Illinois - Uniform Prior Authorization Form
Verified: Feb 27, 2024Indiana - Uniform Prior Authorization Form
Verified: Feb 27, 2024Louisiana - Uniform Prior Authorization Form
Verified: Feb 27, 2024Michigan - Uniform Prior Authorization Form
Verified: Feb 27, 2024Minnesota - Uniform Prior Authorization Form
Verified: Feb 27, 2024New Hampshire - Uniform Prior Authorization Form
Verified: Feb 27, 2024New Mexico - Uniform Prior Authorization Form
Verified: Feb 27, 2024Oregon - Uniform Prior Authorization Form
Verified: Feb 27, 2024Texas - Uniform Prior Authorization Form
Complete Letter of Medical Necessity
Coverage Authorization Appeals
Formulary Exception Letter
PA Checklist
Appeals Checklsit
Learn More

Benefits investigation

Pfizer Oncology Together Form
Pfizer Oncology Together Form - Spanish
Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information
Learn More

pharmacy

Braftovi preferred pharmacy

Pharmacy List

financial assistance

Braftovi financial assistance options

Co-pay savings program

commercial only
Enroll in Patient Savings Program
HCP Office : Attest & Print Co-Pay Card
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+
Pfizer Oncology Together Form
Pfizer Oncology Together Form - Spanish
Pfizer Patient Assistance Program
Learn More

PubMed™ | Braftovi

Braftovi PubMed™ News

patient education

Braftovi patient education

To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

Pfizer Oncology Patient Access Guide
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Pfizer Oncology Patient Access Guide - Spanish
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Braftovi Patient Brochure
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Braftovi Patient Brochure - Spanish
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Braftovi - Caregiver Brochure
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Braftovi
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Side Effects
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
View How to Take Braftovi
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

people also ask

Braftovi FAQs

Is BRAFTOVI safe to use during pregnancy?No, BRAFTOVI can cause fetal harm when administered to a pregnant woman. There are no available clinical data on its use during pregnancy. Animal studies showed developmental changes and abortifacient effects at doses greater than those used clinically. Pregnant women or females of reproductive potential should be informed of the potential risk to the fetus.
What is the recommendation for breastfeeding while using BRAFTOVI?There are no data on the presence of BRAFTOVI in human milk. Due to potential serious adverse reactions in a breastfed child, women are advised not to breastfeed during BRAFTOVI treatment and for 2 weeks after the last dose.
Does BRAFTOVI affect fertility in males?In male rats, BRAFTOVI showed impacts on fertility at doses approximately 13 times the human exposure at the clinical dose. Males considering BRAFTOVI treatment should discuss potential impacts on fertility with their healthcare provider.
Are there specific precautions for females of reproductive potential using BRAFTOVI?Females of reproductive potential should undergo pregnancy testing before starting BRAFTOVI. Effective contraception is advised during treatment and for 2 weeks after the last dose. Non-hormonal contraception methods are recommended due to potential interactions.
Has BRAFTOVI been studied in pediatric patients?The safety and effectiveness of BRAFTOVI haven't been established in pediatric patients.
What information is available regarding the use of BRAFTOVI in elderly patients?Clinical studies included elderly patients (aged 65 and older) with BRAF mutation-positive melanoma, metastatic CRC, and NSCLC. No significant differences in safety or effectiveness were observed between older and younger patients.
Are there recommended dosage adjustments for patients with hepatic impairment?No dosage adjustment is recommended for patients with mild hepatic impairment. However, there's no established dosage for those with moderate or severe hepatic impairment.
Is there a recommended BRAFTOVI dosage adjustment for patients with renal impairment?No dosage adjustment is recommended for patients with mild to moderate renal impairment. There isn't a recommended dosage for those with severe renal impairment.
FAQ Data Source